Hemorrhagic Macular Infarction after Intravitreal Bevacizumab for Chronic Multifocal Central Serous Chorioretinopathy

We hereby report a case of hemorrhagic macular infarction after intravitreal bevacizumab for chronic multifocal central serous chorioretinopathy (CSC). Issues regarding safety and adverse effects of bevacizumab are discussed. To the best of our knowledge, this is the first reported case of hemorrhag...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelkar, Aditya, Gandhi, Poonam, Amoaku, Winfried, Kelkar, Jai, Kelkar, Shreekant, Raut, Priyanka, Shah, Rachana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2014
Materias:
Published online: July, 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130817/
https://www.ncbi.nlm.nih.gov/pubmed/25126075
http://dx.doi.org/10.1159/000365442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130817/
https://www.ncbi.nlm.nih.gov/pubmed/25126075
http://dx.doi.org/10.1159/000365442

Ejemplares similares